Yumin Zhang

12PUBLICATIONS
49CO-AUTHORS
PharmacogenomicsMolecular targetsMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.

|Sep 08, 2025
Discovery and mechanistic insights of dibenzoylmethane as a broad spectrum inhibitor of coronavirus.

Yuan Sun, Xiaoyang Shu, Lu Chen

|Apr 22, 2025
Substrate recognition and cleavage mechanism of the monkeypox virus core protease.

Yan Gao, Xiong Xie, Xiaoyu Zhang

|Mar 05, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1.

Xiong Xie, Qiaoshuai Lan, Jinyi Zhao

|Nov 22, 2023
Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry.

Haofeng Wang, Qi Yang, Xiaoce Liu

|Sep 22, 2023
A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir.

Yumin Zhang, Yuan Sun, Yuanchao Xie

Pageof 2

Frequent Collaborators

11 joint publications

Leike Zhang

4 joint publications

Gengfu Xiao

4 joint publications

Jingshan Shen

4 joint publications

Hong Liu